Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women
Open Access
- 1 October 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 11 (10) , 1400-1405
- https://doi.org/10.1002/jbmr.5650111005
Abstract
Calcium absorption declines with age. Because 1,25-dihydroxyvitamin D (1,25(OH)2D) is the major hormone controlling calcium absorption, changes in vitamin D metabolism may account for the malabsorption of aging. Serum levels of 1,25(OH)2D have been reported to either decrease or remain unchanged with age. To assess the effect of aging on renal production of 1,25(OH)2D, we evaluated the response of renal 25OHD 1α hydroxylase to human parathyroid hormone (hPTH(1-34) stimulation in 119 women ages 25-83 years. In this population, baseline serum 25OHD and 1,25(OH)2D values did not significantly change with age, but serum iPTH (r = 0.44; p < 0.001) and serum creatinine (r = 0.31; p < 0.01) increased with age. However, the stimulatory activity of hPTH(1-34) on the renal production of 1,25(OH)2D declined with age (r3 = -0.36; p < 0.001) and was most apparent after age 75, being 50% less than that of younger women. Besides age, the production of 1,25(OH)2D was found to be dependent on baseline serum iPTH (r = -0.31; p < 0.0001). Administration of hPTH(1-34) led to suppression of endogenous PTH, and suppressibility of endogenous PTH declined with age (r = 0.53; p < 0.0001). The increase in serum PTH and decreased suppressibility of PTH with age could be due to mild secondary hyperparathyroidism. The increase in PTH with age is probably responsible for maintaining normal serum 1,25(OH)2D levels in elderly subjects; however, decreased metabolism of 1,25(OH)2D in the elderly could also maintain normal serum 1,25(OH)2D levels.Keywords
Funding Information
- NIH (AG10358, UO1-AG10373)
This publication has 41 references indexed in Scilit:
- The effects of menopause and age on calcitropic hormones: A cross-sectional study of 655 healthy women aged 35 to 90Journal of Bone and Mineral Research, 1995
- Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3Journal of Clinical Endocrinology & Metabolism, 1994
- Direct inhibitory effect of amino-terminal parathyroid hormone fragment [PTH(1–34)] on PTH secretion from bovine parathyroid primary cultured cells in vitroBiochemical and Biophysical Research Communications, 1991
- Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin d, and parathyroid hormone in postmenopausal womenJournal of Bone and Mineral Research, 1990
- Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women.Journal of Clinical Investigation, 1989
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- RENAL IMPAIRMENT AND ITS EFFECTS ON CALCIUM METABOLISM IN ELDERLY WOMENAge and Ageing, 1984
- Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic PatientsNew England Journal of Medicine, 1981
- MODULATION OF PLASMA 1,25-DIHYDROXYVITAMIN D IN MAN BY STIMULATION AND SUPPRESSION TESTSThe Lancet, 1979
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979